 Sharon Poisson
Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 37 | 2026 | 1287 | 4.860 |
Why?
| | Ischemic Attack, Transient | 10 | 2023 | 71 | 2.300 |
Why?
| | Brain Ischemia | 11 | 2023 | 362 | 1.730 |
Why?
| | Foramen Ovale, Patent | 2 | 2023 | 11 | 0.930 |
Why?
| | Atherosclerosis | 2 | 2022 | 411 | 0.660 |
Why?
| | Motor Disorders | 1 | 2019 | 17 | 0.560 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2019 | 160 | 0.520 |
Why?
| | Neurology | 2 | 2024 | 117 | 0.440 |
Why?
| | Sex Factors | 7 | 2026 | 2136 | 0.440 |
Why?
| | Kynurenine | 2 | 2025 | 114 | 0.410 |
Why?
| | Intracranial Hemorrhages | 1 | 2014 | 107 | 0.400 |
Why?
| | Cerebral Hemorrhage | 1 | 2014 | 125 | 0.390 |
Why?
| | Status Epilepticus | 1 | 2014 | 71 | 0.390 |
Why?
| | Endarterectomy, Carotid | 2 | 2011 | 64 | 0.380 |
Why?
| | Carotid Stenosis | 2 | 2011 | 107 | 0.360 |
Why?
| | Sex Characteristics | 5 | 2024 | 799 | 0.350 |
Why?
| | Cross Infection | 2 | 2016 | 261 | 0.350 |
Why?
| | Risk Factors | 13 | 2026 | 11017 | 0.340 |
Why?
| | Male | 34 | 2026 | 73950 | 0.330 |
Why?
| | Female | 35 | 2026 | 80076 | 0.330 |
Why?
| | Humans | 48 | 2026 | 147293 | 0.320 |
Why?
| | Neuroimaging | 3 | 2023 | 309 | 0.320 |
Why?
| | Aged | 23 | 2025 | 26514 | 0.320 |
Why?
| | Young Adult | 12 | 2026 | 14437 | 0.310 |
Why?
| | Aged, 80 and over | 16 | 2025 | 8430 | 0.300 |
Why?
| | Emergency Service, Hospital | 6 | 2023 | 2416 | 0.290 |
Why?
| | Catheter-Related Infections | 1 | 2010 | 98 | 0.280 |
Why?
| | Disability Evaluation | 2 | 2021 | 312 | 0.270 |
Why?
| | Risk Assessment | 6 | 2025 | 3784 | 0.260 |
Why?
| | Middle Aged | 23 | 2026 | 36821 | 0.260 |
Why?
| | Patient Care | 1 | 2009 | 121 | 0.260 |
Why?
| | Cerebral Arterial Diseases | 2 | 2019 | 50 | 0.260 |
Why?
| | Urinary Tract Infections | 1 | 2010 | 212 | 0.260 |
Why?
| | Clinical Clerkship | 1 | 2009 | 109 | 0.260 |
Why?
| | Patients | 1 | 2009 | 184 | 0.250 |
Why?
| | Endovascular Procedures | 2 | 2025 | 395 | 0.240 |
Why?
| | Cognition | 2 | 2025 | 1286 | 0.240 |
Why?
| | Retrospective Studies | 18 | 2025 | 17560 | 0.240 |
Why?
| | Adult | 17 | 2026 | 41405 | 0.240 |
Why?
| | Tryptophan | 2 | 2025 | 183 | 0.240 |
Why?
| | United States | 13 | 2023 | 16313 | 0.230 |
Why?
| | Educational Measurement | 1 | 2009 | 332 | 0.230 |
Why?
| | Cohort Studies | 6 | 2024 | 6099 | 0.220 |
Why?
| | Arterial Occlusive Diseases | 1 | 2025 | 90 | 0.210 |
Why?
| | Thrombectomy | 1 | 2025 | 79 | 0.210 |
Why?
| | Databases, Factual | 3 | 2026 | 1504 | 0.200 |
Why?
| | Theft | 1 | 2022 | 2 | 0.190 |
Why?
| | Pneumonia | 2 | 2021 | 636 | 0.190 |
Why?
| | Cognitive Dysfunction | 2 | 2025 | 479 | 0.180 |
Why?
| | Migraine Disorders | 1 | 2024 | 115 | 0.180 |
Why?
| | Activities of Daily Living | 1 | 2025 | 449 | 0.180 |
Why?
| | Psychomotor Performance | 1 | 2025 | 326 | 0.180 |
Why?
| | Adolescent | 8 | 2026 | 22825 | 0.170 |
Why?
| | Metabolomics | 2 | 2024 | 736 | 0.170 |
Why?
| | Emergency Medical Services | 3 | 2022 | 691 | 0.170 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2022 | 149 | 0.170 |
Why?
| | Dizziness | 2 | 2012 | 101 | 0.170 |
Why?
| | Colorado | 3 | 2026 | 4591 | 0.170 |
Why?
| | Metabolome | 1 | 2024 | 391 | 0.160 |
Why?
| | Education, Medical | 1 | 2024 | 277 | 0.160 |
Why?
| | Cerebrovascular Disorders | 1 | 2021 | 106 | 0.160 |
Why?
| | Prevalence | 4 | 2022 | 2889 | 0.160 |
Why?
| | Carotid Artery, Internal, Dissection | 1 | 2020 | 14 | 0.160 |
Why?
| | Clinical Competence | 1 | 2009 | 1260 | 0.160 |
Why?
| | Case-Control Studies | 3 | 2024 | 3660 | 0.160 |
Why?
| | Clinical Trials as Topic | 2 | 2019 | 1072 | 0.160 |
Why?
| | Vertebral Artery Dissection | 1 | 2020 | 31 | 0.160 |
Why?
| | Hypertension | 2 | 2024 | 1280 | 0.160 |
Why?
| | Severity of Illness Index | 2 | 2026 | 2973 | 0.150 |
Why?
| | Age Distribution | 1 | 2020 | 406 | 0.150 |
Why?
| | Sex Distribution | 1 | 2020 | 390 | 0.150 |
Why?
| | Incidence | 3 | 2022 | 2954 | 0.150 |
Why?
| | Aspirin | 2 | 2013 | 406 | 0.140 |
Why?
| | Neurologic Examination | 1 | 2019 | 132 | 0.140 |
Why?
| | Healthcare Disparities | 1 | 2025 | 740 | 0.140 |
Why?
| | Platelet Aggregation Inhibitors | 2 | 2013 | 499 | 0.140 |
Why?
| | Aftercare | 1 | 2020 | 225 | 0.130 |
Why?
| | Internationality | 1 | 2019 | 156 | 0.130 |
Why?
| | Follow-Up Studies | 6 | 2020 | 5476 | 0.130 |
Why?
| | Intracranial Arterial Diseases | 1 | 2017 | 11 | 0.130 |
Why?
| | Nutrition Surveys | 1 | 2019 | 279 | 0.130 |
Why?
| | Survivors | 3 | 2025 | 528 | 0.130 |
Why?
| | Guideline Adherence | 1 | 2022 | 590 | 0.130 |
Why?
| | Sinus Thrombosis, Intracranial | 1 | 2017 | 25 | 0.130 |
Why?
| | Cerebral Arteries | 1 | 2017 | 59 | 0.120 |
Why?
| | Registries | 1 | 2026 | 2434 | 0.120 |
Why?
| | Health Services Accessibility | 1 | 2025 | 1121 | 0.120 |
Why?
| | Secondary Prevention | 1 | 2018 | 253 | 0.120 |
Why?
| | Practice Guidelines as Topic | 2 | 2022 | 1598 | 0.110 |
Why?
| | Heart Septal Defects, Atrial | 1 | 2016 | 59 | 0.110 |
Why?
| | Machine Learning | 1 | 2021 | 596 | 0.110 |
Why?
| | Soft Tissue Infections | 1 | 2015 | 40 | 0.110 |
Why?
| | Magnetic Resonance Angiography | 1 | 2017 | 251 | 0.110 |
Why?
| | Cost-Benefit Analysis | 1 | 2018 | 653 | 0.110 |
Why?
| | Ambulatory Care | 1 | 2020 | 625 | 0.110 |
Why?
| | Pregnancy Complications | 1 | 2020 | 606 | 0.100 |
Why?
| | Age Factors | 1 | 2022 | 3372 | 0.100 |
Why?
| | Patient Readmission | 1 | 2020 | 777 | 0.100 |
Why?
| | Cross-Sectional Studies | 6 | 2025 | 6011 | 0.100 |
Why?
| | Internal Medicine | 1 | 2015 | 280 | 0.090 |
Why?
| | Information Seeking Behavior | 1 | 2012 | 40 | 0.090 |
Why?
| | Prognosis | 3 | 2021 | 4383 | 0.090 |
Why?
| | Central Nervous System Diseases | 1 | 2012 | 75 | 0.090 |
Why?
| | Electroencephalography | 1 | 2014 | 570 | 0.080 |
Why?
| | Child | 5 | 2022 | 22979 | 0.080 |
Why?
| | Education, Medical, Graduate | 1 | 2015 | 568 | 0.080 |
Why?
| | Infant, Newborn | 1 | 2022 | 6543 | 0.080 |
Why?
| | Anticoagulants | 2 | 2017 | 751 | 0.080 |
Why?
| | Executive Function | 2 | 2025 | 472 | 0.080 |
Why?
| | Odds Ratio | 3 | 2021 | 1084 | 0.080 |
Why?
| | Patient Discharge | 3 | 2022 | 1002 | 0.080 |
Why?
| | Neuropsychological Tests | 2 | 2025 | 1145 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1518 | 0.080 |
Why?
| | Sepsis | 1 | 2016 | 671 | 0.070 |
Why?
| | Critical Care | 1 | 2015 | 705 | 0.070 |
Why?
| | Predictive Value of Tests | 3 | 2021 | 2133 | 0.070 |
Why?
| | Dyslipidemias | 1 | 2011 | 185 | 0.070 |
Why?
| | Catheters, Indwelling | 1 | 2010 | 96 | 0.070 |
Why?
| | Tissue Plasminogen Activator | 1 | 2011 | 248 | 0.070 |
Why?
| | Disease Progression | 1 | 2017 | 2890 | 0.070 |
Why?
| | Inflammation | 1 | 2021 | 2920 | 0.070 |
Why?
| | Critical Illness | 1 | 2015 | 907 | 0.070 |
Why?
| | Fibrinolytic Agents | 1 | 2011 | 303 | 0.070 |
Why?
| | Diagnostic Imaging | 1 | 2011 | 342 | 0.070 |
Why?
| | Curriculum | 1 | 2015 | 1082 | 0.070 |
Why?
| | Infant | 1 | 2022 | 10194 | 0.070 |
Why?
| | Cerebrovascular Circulation | 1 | 2010 | 293 | 0.070 |
Why?
| | Inpatients | 2 | 2024 | 556 | 0.070 |
Why?
| | Electrocardiography | 1 | 2011 | 675 | 0.070 |
Why?
| | Antihypertensive Agents | 1 | 2011 | 522 | 0.060 |
Why?
| | Child, Preschool | 1 | 2022 | 12016 | 0.060 |
Why?
| | Medicare | 2 | 2023 | 915 | 0.060 |
Why?
| | Nervous System Diseases | 1 | 2009 | 288 | 0.060 |
Why?
| | Brain | 2 | 2023 | 3009 | 0.050 |
Why?
| | Atrial Fibrillation | 1 | 2011 | 560 | 0.050 |
Why?
| | Infarction | 1 | 2023 | 9 | 0.050 |
Why?
| | Hospital Mortality | 2 | 2021 | 1043 | 0.050 |
Why?
| | Individuality | 1 | 2025 | 149 | 0.050 |
Why?
| | Automobile Driving | 1 | 2025 | 159 | 0.050 |
Why?
| | Time-to-Treatment | 1 | 2025 | 258 | 0.050 |
Why?
| | Diabetes Mellitus | 1 | 2011 | 1107 | 0.050 |
Why?
| | Middle Cerebral Artery | 1 | 2022 | 57 | 0.050 |
Why?
| | Infarction, Middle Cerebral Artery | 1 | 2022 | 41 | 0.050 |
Why?
| | Postural Balance | 1 | 2025 | 254 | 0.040 |
Why?
| | Emergency Medical Dispatch | 1 | 2022 | 4 | 0.040 |
Why?
| | Attention | 1 | 2025 | 464 | 0.040 |
Why?
| | Urban Population | 1 | 2025 | 502 | 0.040 |
Why?
| | Up-Regulation | 1 | 2025 | 848 | 0.040 |
Why?
| | Information Systems | 1 | 2022 | 57 | 0.040 |
Why?
| | Multivariate Analysis | 2 | 2016 | 1550 | 0.040 |
Why?
| | Time Factors | 2 | 2025 | 7173 | 0.040 |
Why?
| | Treatment Outcome | 3 | 2025 | 11947 | 0.040 |
Why?
| | Rural Population | 1 | 2025 | 684 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 2 | 2023 | 3980 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2019 | 3448 | 0.040 |
Why?
| | Comorbidity | 2 | 2016 | 1672 | 0.040 |
Why?
| | Length of Stay | 1 | 2025 | 1371 | 0.040 |
Why?
| | Communication | 1 | 2024 | 989 | 0.030 |
Why?
| | Dura Mater | 1 | 2017 | 40 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2021 | 1147 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 367 | 0.030 |
Why?
| | Chronic Disease | 1 | 2021 | 1844 | 0.030 |
Why?
| | California | 1 | 2016 | 477 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2018 | 1344 | 0.030 |
Why?
| | Cardiac Catheterization | 1 | 2018 | 572 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1281 | 0.030 |
Why?
| | Biomarkers | 1 | 2025 | 4351 | 0.020 |
Why?
| | Ticlopidine | 1 | 2013 | 52 | 0.020 |
Why?
| | Online Systems | 1 | 2012 | 20 | 0.020 |
Why?
| | Diagnostic Self Evaluation | 1 | 2012 | 25 | 0.020 |
Why?
| | Global Health | 1 | 2016 | 406 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2023 | 2791 | 0.020 |
Why?
| | Medical History Taking | 1 | 2012 | 119 | 0.020 |
Why?
| | Uncompensated Care | 1 | 2012 | 21 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2012 | 330 | 0.020 |
Why?
| | Ambulances | 1 | 2012 | 52 | 0.020 |
Why?
| | Geography | 1 | 2012 | 187 | 0.020 |
Why?
| | Symptom Assessment | 1 | 2012 | 137 | 0.020 |
Why?
| | Logistic Models | 1 | 2016 | 2142 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2013 | 1046 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2012 | 538 | 0.020 |
Why?
| | Health Surveys | 1 | 2012 | 522 | 0.020 |
Why?
| | Blood Platelets | 1 | 2013 | 381 | 0.020 |
Why?
| | Emergency Medicine | 1 | 2012 | 283 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2013 | 2080 | 0.020 |
Why?
| | Self Report | 1 | 2012 | 887 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2012 | 1342 | 0.020 |
Why?
| | Pregnancy | 1 | 2020 | 7274 | 0.020 |
Why?
| | Research Design | 1 | 2013 | 1157 | 0.020 |
Why?
|
|
Poisson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|